Centre of Expertise Palliative Care, Department General Practice, Julius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, the Netherlands.
Academic Hospice Demeter, de Bilt, the Netherlands.
BMC Prim Care. 2023 Apr 15;24(1):101. doi: 10.1186/s12875-023-02049-x.
Several preventive medications and supplements become inappropriate in the last phase of life due to increased risk of adverse events caused by changed pharmacokinetics, drug-drug interactions, and changed care goals. Information on these preventive medication and supplements use in patients with a life-limiting illness in the home-care setting is limited. The primary aim of this study was to assess the use of four different groups of preventive drugs and supplements, which are inappropriate in adult patients with a life-limiting illness, living at home in the last year of life. The secondary aims were to assess reasons for discontinuing these drugs as documented in the general practitioners' patient file and whether these reasons affected the time between medication discontinuation and death.
We performed a retrospective cohort study using the routine primary care database of the Julius General Practitioners' Network of the University Medical Centre Utrecht, a database consisting of routine care data from GPs from the city of Utrecht and its vicinity. Patients in the homecare setting with a life-limiting illness, diagnosed at least one year before death, were included. Descriptive analyses were used to describe the study population and the frequency of starting, using, and discontinuing medication and supplements in the last year of life.
A total of 458 of 666 included patients (69%) used at least one preventive drug in the last year of life. Vitamins were used by 36% of the patients, followed with 35% using cholesterol-lowering medication, 24% using calcium supplements and 9% using bisphosphonates. Bisphosphonates were discontinued by 70% of the users, calcium supplements by 61%, vitamins by 56% and cholesterol-lowering medication by 48% of the users, with a median interval between day of discontinuation and death of 119, 60, 110 and, 65 days, respectively. The median time between medication or supplement discontinuation and death was longest in patients with side effects and who had medication reviews.
Many patients in their last phase of life in the home-care setting use inappropriate medication and supplements. Timely medication review may contribute to optimise medication use in the last year of life.
由于药代动力学改变、药物相互作用和治疗目标改变导致不良事件风险增加,几种预防药物和补充剂在生命末期变得不合适。关于这些预防药物和补充剂在生命有限的家庭护理患者中的使用信息有限。本研究的主要目的是评估在生命末期在家中生活的患有生命有限疾病的成年患者中使用四类不同的预防药物和补充剂的情况,这些药物和补充剂不合适。次要目的是评估在全科医生的患者档案中记录的停止使用这些药物的原因,以及这些原因是否影响药物停止使用和死亡之间的时间。
我们使用乌得勒支大学医学中心 Julius 全科医生网络的常规初级保健数据库进行了回顾性队列研究,该数据库由来自乌得勒支市及其周边地区的全科医生的常规护理数据组成。纳入了在家中护理环境中患有生命有限疾病、至少在死亡前一年被诊断出患有该疾病的患者。使用描述性分析来描述研究人群以及在生命的最后一年开始、使用和停止使用药物和补充剂的频率。
在 666 名纳入的患者中,共有 458 名(69%)在生命的最后一年使用了至少一种预防药物。患者中有 36%使用了维生素,其次是 35%使用了降胆固醇药物,24%使用了钙补充剂,9%使用了双膦酸盐。使用双膦酸盐的患者中有 70%停药,使用钙补充剂的患者中有 61%停药,使用维生素的患者中有 56%停药,使用降胆固醇药物的患者中有 48%停药,停药后死亡的中位数间隔为 119、60、110 和 65 天。在有副作用和药物审查的患者中,药物或补充剂停药和死亡之间的中位数时间最长。
在家中护理环境中生命末期的许多患者使用不合适的药物和补充剂。及时进行药物审查可能有助于优化生命最后一年的药物使用。